Oncology company with a new method to treat cancers wins UChicago startup competition

Intellia Therapeutics (NASDAQ: NTLA) and Rocket Pharmaceuticals (NASDAQ: RCKT) are gene-editing biotechs that want to offer what few others can: cures for...

University of Alberta alum, Michel Sadelain, is being recognized for his major discovery in the cancer-fighting immunotherapy field — one that is already...

Investment fund Guinness Global Innovators makes money for investors by taking stakes in companies that are involved in leading edge technology everything...

The surgeon general has determined that investing in artificial intelligence (AI) has proven to be advantageous to your financial health. OK, not really....

Apple makes employees sign an agreement designed to chill employee mobility and competition, the chip startup alleges.

Astrazeneca shares rose after a positive trial of a drug for a common type of breast cancer. The study found datopotamab deruxtecan showed a 'statistically...

Pharmaceutical companies are harnessing artificial intelligence (AI) to speed up the traditionally arduous process of clinical trials, potentially saving...

Bone marrow cancer patients will now be able to receive a treatment that extends life after NHS spending chiefs U-turned on their decision not to fund it....

Key Points Sequoia Capital is among notable venture firms that have expanded in New York, opening an office there in July. IPOs of companies including...

In our modern age, the power of gene editing is undeniable. After years of foundational scientific research, it's now becoming possible to treat illnesses...

A man diagnosed with an aggressive and incurable brain tumour is fundraising for experimental treatment abroad, after exhausting NHS care. Richard Orna, 38,...

Health care stocks were steady pre-bell Friday, with the Health Care Select Sector SPDR Fund ( XLV ) and iShares Biotechnology ETF ( IBB ) recently...

(RTTNews) - Merck & Co Inc. (MRK), known as MSD outside of the U.S. and Canada, announced Friday positive topline results from the Phase 3 KEYNOTE-A39...

Key Points Singapore-headquartered Silent Eight wants to be "IPO ready" by the end of 2025 with a view to listing on the tech-heavy Nasdaq in the U.S, its...

During his long and distinguished investing career, Berkshire Hathaway CEO Warren Buffett has readily admitted to having trouble comprehending some of the...

The Silicon Valley company joins several other US investment firms, including Sequoia Capital, that have made similar moves under pressure in Washington.

(RTTNews) - Seagen Inc. (SGEN) and Astellas Pharma Inc. reported positive topline results from the Phase 3 EV-302 trial for PADCEV in combination with...

LOS ALAMOS, N.M. (AP) Los Alamos was the perfect spot for the U.S. governments top-secret Manhattan Project. Almost overnight, the ranching enclave on a...

British scientists are using pioneering stem cell technology to grow mini-brains in a laboratory to trial a large range of potential new treatments for...

Evaxion Biotech A/S EVAX collaborated with Afrigen Biologics to develop a prophylactic vaccine based on Evaxion's EDEN-discovered gonorrhea targets....